Recursion Pharmaceuticals, Inc. RXRX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Recursion Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s free cash flow margin?
- Recursion Pharmaceuticals, Inc. (RXRX) reported free cash flow margin of -490.7% in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s free cash flow margin changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s free cash flow margin increased by 26.2% year-over-year, from -665.2% to -490.7%.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s free cash flow margin?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s free cash flow margin has grown at a -18.6% compound annual growth rate (CAGR), from -1,416.4% to -506.5%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.